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TWO-ELECTRON DONATING
PHENOTHIAZINES AND USE THEREOF

aqueous electrolytes. Only a handful of organic electroactive
materials are capable of dissolving at concentrations greater
than 0.5M.7· 9

PRIORITY
5

This invention claims priority to U.S. Provisional Application Ser. No. 62/378,443, filed Aug. 23, 2016.

Accordingly, there exists a need for stable electroactive
materials having sufficient atom economy for use in nonaqueous redox flow batteries.
SUMMARY OF INVENTION

GOVERNMENT INTEREST
10

This invention was made with govermnent support under
grant numbers 1300653 and 1355438 awarded by the
National Science Foundation. The government has certain
rights in the invention.
15

TECHNICAL FIELD
The presently-disclosed subject matter generally relates to
phenothiazine derivatives. In particular, certain embodiments of the presently-disclosed subject matter relate to
phenothiazine derivatives having stable first and second
oxidation states and the use thereof for redox flow batteries.

20

The presently-disclosed subject matter includes compounds that can be used stable two-electron redox-active
materials. The presently-disclosed subject matter further
includes rechargeable batteries, including non-aqueous
redox flow batteries and the use of two-electron redox-active
materials as electrolytic materials.
In some embodiments of the presently-disclosed subject
matter, a compound is provided, with a structure as set forth
below

INTRODUCTION
25

Redox flow batteries (RFBs ), which function by storing
electrochemical energy in liquid electrolyte formulations,
are promising technologies for energy storage on medium to
large scales. 1 Since the energy is stored in a liquid form,
increasing the capacity of RFBs is largely a matter of
increasing the size of active-material storage tanks. Current
state-of-the-art RFBs are based upon aqueous vanadium
chemistry. While such RFBs are robust and long-lived, they
rely upon expensive transition metals as active materials that
form redox active species. Additionally, these RFBs are
aqueous-based and, therefore, are limited by the electrochemical stability window of water (about 1.5 V). 2
One possibility for accessing higher voltages includes the
use of non-aqueous electrolytes, which are generally not
compatible with transition metal-based active materials.
Although such systems have the potential for increasing the
voltage of the system and reducing cost by exchanging
scarce transition metals for plentiful carbon-based materials,
the development and commercialization of organic nonaqueous redox flow batteries is largely in its infancy due to
challenges in long term stability,3 atom economy,4 and
solubility/energy density. 5
For example, due to stability requirements for extended
periods of time in both neutral and oxidized forms, only a
limited number of molecular classes have been used for
catholyte (positive electrolyte) material in preliminary allorganic non-aqueous RFBs, including dialkoxybenzenes 6 ,
stabile N-oxo radicals 7, and phenothiaizines. 8 •9 These molecules are electron rich and are therefore capable of donating
an electron when paired with an anolyte (negative electrolyte) material. However, molecules used as charge storage
materials must also function with excellent atom economy.
Vanadium-based aqueous RFBs have excellent atom
economy with the ability to store an electron with 50 amu of
mass. Organic materials, on the other hand, generally have
molecular weights of about 150-300 amu due to need for
stabilizing structures to allow for reversible electrochemical
performance. This presents a challenge for organic nonaqueous systems as this represents a 65-85% reduction in
atom economy relative to vanadium. Related to the
increased molecular weights of organic materials are the
lower concentrations of active species achieved in non-

30

35

In some embodiments, R 1 and R 2 are independently selected
from H, N(R') 2 , N(R") 2 , OR', OR", and R" so long as when
R 1 is H, R 2 is not H. In some instances, R, R' and R" are
independently selected from alkyl, aryl, alkylaryl, alkoxyaryl, alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroalkyl, glycol, polyether, haloaryl, a negative electrolyte, a
polymerizable unit, and a polymer.
In some embodiments, the compound is an N-substituted
phenothiazine with a structure represented by:

40
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FIG. 2 is a schematic showing synthesis ofN-substituted
3, 7-dimethoxyphenothiazine derivatives.

5

10

FIG. 3 is a graph showing cyclic voltammograms of
DMeOEPT, DMeOMEPT, and DMeOMEEPT in PC/LiBF 4 .
FIG. 4 is a graph showing UV-vis spectra monitored at
various potentials for a solution ofDMeOEPT at 0.375 mM
in a spectroelectrochemical cell containing Pt honeycomb
electrode card and a freshly anodized Ag/AgCl electrode in
0.lM LiTFSI in PC.
FIG. 5 shows graphs illustrating DMeOEPT half-cell
cycling accessing only the first oxidation state (left) and both
first and second oxidations (right).

15
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In some embodiments, the N-substituted phenothiazine
compounds presently disclosed include one or more solubilizing groups tethered to the phenothiazine core via a
linkage at the N-position, also denoted as the 10 position.
The solubilizing group tethered to the phenothiazine core
can, in some instances, increase solubility of the compound
in organic electrolytes. \
In some embodiments, the N-substituted phenothiazine
compounds contain one or more electron-donating functional groups attached at the 3 and/or 7 position. Suitable
electron-donating functional groups include, but are not
limited to, alkoxy groups, amino groups, or a combination
thereof. In some embodiments, substituents can be positioned at the 1, 2, 4, 6, 8, and/or 9 positions as long as there
is an alkoxy group and/or amino group and/or other suitable
electron-donating functional group at the 3 and/or 7 positions. Specifically, the minimum number of substituents the
present inventors have demonstrated that is needed is at the
3, 7, and 10 (or 3, 7, and N; N is the same as 10). It is
contemplated that the 3 and 10 (N) positions can enable the
second charge to be stabilized.
In some embodiments, compounds disclosed herein find
use in non-aqueous redox flow batteries. In some instances,
the non-aqueous redox flow battery includes a negative
electrode immersed in a first non-aqueous liquid electrolyte
solution; a positive electrode immersed in a second nonaqueous liquid electrolyte solution, with the second nonaqueous liquid electrolyte solution including a compound as
disclosed herein; and a semi-permeable separator interposed
between the negative and positive electrodes.
DESCRIPTION OF THE DRAWINGS
The novel features of the invention are set forth with
particularity in the appended claims. A better understanding
of the features and advantages of the present invention will
be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the
principles of the invention are used, and the accompanying
drawings of which:
FIG. 1 is a graph showing cyclic voltammograms of
DMeOEPT, DMeOMEPT, and DMeOMEEPT, performed
with 10 mM analyte in 0.5M LiPF 6 in PC at a scan rate of
100 mV/s.

FIG. 6 shows graphs illustrating DMeOMEPT half-cell
cycling accessing only the first oxidation state (left) and both
first and second oxidations (right).
FIG. 7 shows graphs illustrating DMeOMEEPT half-cell
cycling accessing only the first oxidation state (left) and both
first and second oxidations (right).
DESCRIPTION OF EXEMPLARY
EMBODIMENTS

25
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The details of one or more embodiments of the presentlydisclosed subject matter are set forth in this document.
Modifications to embodiments described in this document,
and other embodiments, will be evident to those of ordinary
skill in the art after a study of the information provided in
this document. The information provided in this document,
and particularly the specific details of the described exemplary embodiments, is provided primarily for clearness of
understanding and no unnecessary limitations are to be
understood therefrom. In case of conflict, the specification of
this document, including definitions, will control.
The presently-disclosed subject matter includes N-substituted phenothiazine compounds. The phenothiazine forms a
redox-active core of the N-substituted phenothiazine compounds. In some embodiments, one or more solubilizing
groups may be tethered to the phenothiazine core via a
linkage at the N-position. The solubilizing group tethered to
the phenothiazine core increases solubility of the compound
in organic electrolytes. Additionally or alternatively, in some
embodiments, the N-substituted phenothiazine compounds
contain one or more electron-donating functional groups
attached at the 3 and/or 7 position. Suitable electron-donating functional groups include, but are not limited to, alkoxy
groups, amino groups, or a combination thereof.
For example, in some embodiments, the N-substituted
phenothiazine compound includes an alkoxyphenothiazine
according to the formula set forth below:

55

60

wherein R is an alkyl or (poly)ether and R' is an alkyl.
65

In some embodiments, the N-substituted phenothiazine
compound includes a dialkoxyphenothiazine according to
the formula set forth below:

US 10,954,201 B2
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wherein R is selected from alkyl, aryl, alkylaryl, alkoxyaryl,
alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroalkyl, glycol, polyether, haloaryl, a negative electrolyte, a polymerizable unit, and a polymer, and R' is selected from alkyl, aryl,
alkylaryl, alkoxyaryl, alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroalkyl, glycol, polyether, haloaryl, a negative
electrolyte, a polymerizable unit, and a polymer.
In some embodiments, the N-substituted phenothiazine
compound includes a monoaminophenothiazine according
to the formula set forth below:

6

10

15

20

25

30

wherein R is selected from alkyl, aryl, alkylaryl, alkoxyaryl,
alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroalkyl, glycol, polyether, haloaryl, a negative electrolyte, a polymerizable unit, and a polymer, and R' is selected from alkyl, aryl,
alkylaryl, alkoxyaryl, alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroalkyl, glycol, polyether, haloaryl, a negative
electrolyte, a polymerizable unit, and a polymer.

35

40

In some embodiments, the N-substituted phenothiazine
compound includes a diaminophenothiazine according to
the formula set forth below:
45

50

55

wherein R is selected from alkyl, aryl, alkylaryl, alkoxyaryl,
alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroalkyl, glycol, polyether, haloaryl, a negative electrolyte, a polymerizable unit, and a polymer, and R' is selected from alkyl, aryl,
alkylaryl, alkoxyaryl, alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroalkyl, glycol, polyether, haloaryl, a negative
electrolyte, a polymerizable unit, and a polymer.
In some embodiments, the N-substituted phenothiazine
compound is according to any one of the following formulae:

60

65

wherein R, R', and R" are independently selected from alkyl,
aryl, alkylaryl, alkoxyaryl, alkylcarboxyl, arylcarbonyl,
haloalkyl, perfluoroalkyl, glycol, polyether, haloaryl, a
negative electrolyte, a polymerizable unit, and a polymer.
Furthermore, in some embodiments of the compound,
substituents can be positioned at the 1, 2, 4, 6, 8, and/or 9
positions as long as there is an alkoxy group and/or amino
group at the 3 and/or 7 positions. Specifically, the minimum
number of substituents the present inventors have demonstrated that is needed is at the 3, 7, and 10 (or 3, 7, and N;
N is the same as 10). It is contemplated that the 3 and 10 (N)
positions can enable the second charge to be stabilized.
"Alkyl" refers to a saturated or unsaturated, branched,
straight-chain or cyclic monovalent hydrocarbon radical
derived by the removal of one hydrogen atom from a single
carbon atom of a parent alkane, alkene or alkyne. Typical
alkyl groups include, but are not limited to, methyl; ethyls
such as ethanyl, ethenyl, ethynyl; propyls such as propan1-yl, propan-2-yl, cyclopropan-1-yl, prop-1-en-1-yl, propl-en-2-yl, prop-2-en-1-yl (ally!), cycloprop-1-en-1-yl;
cycloprop-2-en-1-yl, prop-1-yn-1-yl, prop-2-yn-1-yl, etc.;
butyls such as butan-1-yl, butan-2-yl, 2-methyl-propan-1-yl,
2-methyl-propan-2-yl, cyclobutan-1-yl, but-l-en-1-yl, butl-en-2-yl, 2-methyl-prop-1-en-1-yl, but-2-en-1-yl, but-2-en2-yl, buta-1,3-dien-1-yl, buta-1,3-dien-2-yl, cyclobut-l-en1-yl, cyclobut-l-en-3-yl, cyclobuta-1,3-dien-1-yl, but-1-ynl-yl, but-l-yn-3-yl, but-3-yn-1-yl, etc.; and the like.
Preferably, an alkyl group comprises from 1 to 20 carbon
atoms, more preferably, from 1 to 10 carbon atoms.
"Ary!" refers to a monovalent aromatic hydrocarbon
radical derived by the removal of one hydrogen atom from
a single carbon atom of a parent aromatic ring system.
Typical aryl groups include, but are not limited to, groups
derived from aceanthrylene, acenaphthylene, acephenanthrylene, anthracene, azulene, benzene, chrysene,
coronene,fluoranthene,fluorene,hexacene,hexaphene,hexalene, as-indacene, s-indacene, indane, indene, naphthalene,
octacene, octaphene, octalene, ovalene, penta-2,4-diene,
pentacene, pentalene, pentaphene, perylene, phenalene,
phenanthrene, picene, pleiadene, pyrene, pyranthrene, rubicene, triphenylene, trinaphthalene and the like. Preferably,
an aryl group comprises from 6 to 20 carbon atoms, more
preferably, between 6 to 12 carbon atoms.

US 10,954,201 B2
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8

"Alkylaryl" refers to an acyclic alkyl in which one of the
hydrogen atoms bonded to a carbon atom, is replaced with
an aryl group. Typical arylalkyl groups include, but are not
limited to, benzyl, 2-phenylethan-1-yl, 2-phenylethen-1-yl,
naphthylmethyl, 2-naphthylethan-1-yl, 2-naphthylethen-1yl, naphthobenzyl, 2-naphthophenylethan-1-yl and the like.
Where specific alkyl moieties are intended, the nomenclature arylalkanyl, arylalkenyl and/or arylalkynyl is used.
Preferably, an arylalkyl group is (CcC 30 ) arylalkyl, e.g., the
alkanyl, alkenyl or alkynyl moiety of the arylalkyl group is
(C 1 -C 10 ) and the aryl moiety is (C 6 -C 20 ), more preferably, an
arylalkyl group is (CcC 20 ) arylalkyl, e.g., the alkanyl,
alkenyl or alkynyl moiety of the arylalkyl group is (C 1 -C 8 )
and the aryl moiety is (C 6 -C 12 ).

(I)

5

DMeOEPT

10

(II)

15

"Alkoxyaryl" refers to an ---0-arylalkyl where arylalkyl
is as defined herein.
"Alkylcarboxyl" means a -C(O)R group where R is
alkyl, as defined herein.

20

DMeOMEPT

"Arylcarbonyl" refers to a -C(O)-aryl where aryl is as
defined herein.
"Halogen" or "halo" refers to fluorine, chlorine, bromine
and iodine. Thus, a haloalkyl, refers to an alkyl group
substituted with one or more halogens. A halo aryl refers to
an aryl group substituted with one or more halogens.
"Perfluoroalkyl" refers to alkyl groups in which essentially all of the carbon-bonded hydrogen has been replaced
by fluorine.

(III)

25

30

"Polyether" refers to a functional group containing more
than one ether, which can include aromatic polyethers such
as polyphenyl ether.
Glycols include alcohols in which at least two hydroxyl
groups are attached to different carbon atoms in an organic
compound, including alkylene glycols such as ethylene
glycol and propylene glycol.
A negative electrolyte can include, for example, LiBF4 ,
LiPF 6 , lithium triflate, NaBF 4 , NaPF 6 , and sodium triflate.
A polymer consist of a large number of repeating units
bonded together. A polymerizable unit, in some instances,
can be a monomer, oligomer, or low molecular weight
polymer that is capable of being polymerized upon activation.
In some embodiments, the N-substituted phenothiazine
compounds have stable first and second oxidation states
(e.g., radical cation, dication). For example, suitable N-substituted phenothiazine compounds having stable first and
second oxidation states include, but are not limited to,
two-electron donor compounds having the structure:

DMeOMEEPT
(IV)

(

('YN10

35

0

'--o/--..../ -....../'---o~s~o/'-..../ 0 -....../'---o,,,,.
D(MEEO)MEEPT
40

45

50

In contrast to most phenothiazines, which decompose in
the second oxidation state, the introduction of electrondonating functional groups to the phenothiazine redoxactive core facilitates a reversible second oxidation event
and/or formation of a doubly oxidized species that is stable
for extended periods of time. Accordingly, in some embodiments, the N-substituted phenothiazine compounds
described herein provide stable two-electron redox-active
materials. For example, as illustrated in FIG. 1 and Table 1,
the dimethoxy-substituted phenothiazine derivatives, such
as compounds I-IV shown above, provide stable first and
second oxidations occurring at about 3.4 and 3.9 V vs. Li,
respectively.

R

h:Q
I~
MeO

S

#

55

TABLE 1
Measured half-wave first and second oxidation potentials and
diffusion coefficients.

OMe
60

wherein R is selected from alkyl, aryl, alkylaryl, alkoxyaryl,
alkylcarboxyl, arylcarbonyl, haloalkyl, perfluoroalkyl, glycol, polyether, haloaryl, a negative electrolyte, a polymerizable unit, and a polymer.
In one embodiment, the two-electron donor compounds
include one or more of the structures set forth below:

Compound

II
III
N

65

1" Eox vs. Li (VJ"

2nd Eox vs. Li (VJ"

Diffusion
Coefficient

3.38
3.42
3.41

3.94
3.96
3.98

0.8/0.8
1.0/0.9
0.5/0.5

acyclic voltammetry was performed with 10 mM analyte in 0.5M LiPF 6 in PC at a scan
rate of 100 mV/s.

US 10,954,201 B2
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With regard to Compound IV, oxidation potentials are
0.035 V and 0.625 V vs. ferrocenium/ferrocene in 0.5M
TEATFSI/acetonitrile.
In certain embodiments, the stable first and second oxidations facilitate formation of stable dications in non-aqueous electrolytes without requiring an extensive increase
(e.g., doubling) of molecular weight. By forming stable
dications without extensive increases in molecular weight,
the N-substituted phenothiazine compounds described
herein provide increased atom economy (i.e., molecular
weight per electron). Such atom utilization can be advantageous for both efficiency of the chemical processes and
contribute to a greener chemistry process. In one embodiment, for example, the N-substituted phenothiazine compounds described herein increase atom economy by up to
100% as compared to existing compounds and/or catholytes.
Additionally, in some embodiments, the N-substituted
phenothiazine compounds described herein provide
increased solubility in electrolyte formulations as compared
to existing compounds, such as 2,5-di-tert-butyl-1,4-bis(2methoxyethoxy)benzene (DBBB). In one embodiment, the
glyme substituents provide increased solubility in electrolyte formulations as compared to other derivatives. For
example, as compared to the N-ethyl derivative, which
exhibited a solubility of about 100 mM, the glyme and
diglyme derivatives exhibited higher solubility while retaining stable redox chemistry. In another embodiment, this
solubility in organic solvents permits the use of renewable
earth-abundant elements.
In some embodiments, the N-substituted phenothiazine
compounds described herein provide a multi-electron donor
including high stability and solubility in catholyte formulations. In another embodiment, the catholyte material provides a multi-electron donor that retains high chemical
stability when charged. In a further embodiment, as catholyte energy density is limited due to solubility, stability, and
redox chemistry, the high solubility, ability to act as a
multi-electron donor, and/or high chemical stability of the
compounds described herein significantly increases volumetric energy density as compared to other catholyte materials. For example, when formulated at its solubility limit,
diglyme-dimethoxyphenothiazine may provide approximately 5 times the volumetric energy of DBBB, which has
an energy density of 10 Ah/L when formulated as a catholyte, and is limited by its solubility (0.4M) and redox
chemistry, acting as a single electron donor.
The presently-disclosed subject matter also includes a
method of making an N-substituted phenothiazine derivative. As illustrated in FIG. 2, in some embodiments, the
method includes synthesizing an N-substituted phenothiazine according to previously reported procedures (e.g.,
Odom, 2014 and Kaur, 2015), forming a 3,7-dibromophenothiazine derivative through aromatic dibromination, and
then forming a 3,7-dimethoxyphenothiazine derivative
through methoxylation of the dibromophenothiazine. In one
embodiment, the methoxylation includes treatment with
sodium methoxide and copper (I) iodide in refluxing pyridine. Non-limiting examples of process conditions are provided below in Examples 1-3. In some embodiments, the
reactions are scalable.
The presently-disclosed subject matter also includes a
non-aqueous redox flow battery. In some embodiments, the
non-aqueous redox flow battery includes a negative electrode immersed in a first non-aqueous liquid electrolyte
solution, a positive electrode immersed in a second nonaqueous liquid electrolyte solution, and a semi-permeable
separator interposed between the negative and positive elec-

trodes. In one embodiment, the second non-aqueous liquid
electrolyte solution includes one or more of the N-substituted phenothiazine compounds described herein. For
example, in another embodiment, the one or more N-substituted phenothiazine compounds form the electro-active
material for the catholyte of the non-aqueous redox flow
batteries. In other embodiments, the presently disclosed
invention includes a positive cell comprising a cathode and
a catholyte including one or more of the N-substituted
phenothiazine compounds described herein.
In certain embodiments, the one or more N-substituted
phenothiazine compounds include two electron-donating
groups per phenothiazine, which approximately doubles
electrode capacity, increases atom economy in redox flow
batteries, and/or decreases battery cost as compared to
phenothiazine compounds having one electron-donating
group.
The presently disclosed subject matter is also directed to
making a non-aqueous redox flow battery. The method of
making a non-aqueous redox flow battery includes immersing a negative electrode in a first non-aqueous liquid electrolyte solution, immersing a positive electrode in a second
non-aqueous liquid electrolyte solution, and interposing a
semi-permeable separator between the negative and positive
electrodes. The second non-aqueous liquid electrolyte solution including one or more of the N-substituted phenothiazine compounds described herein.
The non-aqueous liquid electrolyte solution of the presently-disclosed non-aqueous redox flow battery comprises
an organic solvent, which can be selected, for example, from
a carbonate solvent, a nitrile, an ether, an aromatic compound, and an ester. Examples of appropriate carbonate
solvents include, but are not limited to propylene carbonate,
ethylene carbonate, ethyl methylcarbonate, diethylcarbonate, and dimethylcarbonate. Examples of appropriate nitriles
include, but are not limited to acetonitrile, 1,4-dicyanobutane, 1,6-dicyanohexane. Examples of appropriate ethers
include, but are not limited to diethylether, ether, 1,4dioxane, diethylene glycol diethyl ether, ethyl ether, and
tetrahydrofuran. Examples of aromatic compounds include,
but are not limited to, benzene, toluene, pentene, xylenes,
chlorobenzene, anisole, and 1,2-dichlorobenzene. An
example of a glycol includes, but is not limited to, triethylene glycol. Examples of esters include, but are not limited
to, ethyl acetate. Other solvents are described, for example,
in R. M. Darling et al., Pathways to low cost electrochemical
energy storage: a comparison of aqueous and nonaqueous
flow batteries, Energy Environ, Sci., 2014, 7, 3459-3477,
incorporated by reference in its entirety.
In some embodiments, the solvent is a polar solvent. Polar
organic solvents include, but are not limited to, acetonitrile,
acetone, tetrahydrofuran, acetic acid, acetyl acetone, 2-aminoethanol, aniline, anisole, benzene, benzonitrile, benzyl
alcohol, 1-butanol, 2-butanol, i-butanol, 2-butanone, t-butyl
alcohol, carbon disulfide, carbon tetrachloride, chlorobenzene, chloroform, cyclohexanol, cyclohexanone, di-nbutylphthalate, 1, 1-dichloroethane, dichloroethane, diethylamine, diethylene glycol, diglyme, dimethoxyethane
(glyme), N,N-dimethylaniline, N,N-dimethylformamide
(DMF), dimethylphthalate, dimethylsulfoxide (DMSO),
dioxane, ethanol, ethyl acetate, ethyl acetoacetate, ethyl
benzoate, ethylene glycol, heptane, hexane, methanol,
methyl acetate, methyl t-butyl ether (MTBE), methylene
chloride, 1-octanol, 1-pentanol, 2-pentanol, 3-pentanol,
2-pentanone, 3-pentanone, 1-propanol, 2-propanol, pyridine, and tetrahydrofuran(THF).
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In other embodiments, the non-aqueous liquid is an ionic
liquid. When an ionic liquid is used in a non-aqueous
system, this is preferably an inorganic salt made of the
combination of cations including, but not limited thereto,
ammonium, immidazolium, piperidinium, pyrrolidinium,
phophosium and sulfonium cations with anions including,
but not limited thereto, diethyl phosphate, bromide, iodide,
chloride, methylsulfate, dodecylbenzenesulfonate, trimethylpentyl)phosphinate, dicyanamide, decanoate, triflate, bis
(trifluoromethylsulfonyl)imide, 1, 1,2,2-tetrafluoroethanesulfonate, perfluorobutanesulfonate, hexafluorophosphates,
tetrafluoroborates, sulphate, sulfonate, phosphate, thiocyanate, dicyanamide, acetate, trifluoroacetate, nitrate, tetrachloroferrate, tetrathiocyanocobaltate and methylcarbonate.
The non-aqueous redox flow batteries of the presently
disclosed invention include a semi-permeable separator.
Non-limiting examples of suitable separator materials
include sulfonated tetrafluoroethylene-based fluoropolymercopolymers, such as NAFION® type ion exchange membranes, sulfonated poly(ether ether ketones ), polysulfones,
polyethylene, polypropylene, ethylene-propylene copolymers, polyimides, polyvinyldifluorides, and the like, which
can be in the form of membranes, matrix-supported gels,
sheets, films, or panels. Other suitable materials include
porous ceramics, porous insulated metals, cation-conducting
glasses, and zeolites. Other porous films, panels or mesh will
be readily understood by those skilled in the art.
The compounds used in the non-aqueous redox flow
battery has high solubility. In some embodiments, the compound has a solubility of about 0.5M or greater. In some
embodiments, the compound has a solubility of about I .OM
or greater. In some embodiments, the compound has a
solubility of about 2.0M or greater. In some embodiments,
the compound has a solubility of about 3.0M or greater. In
some embodiments, the compound has a solubility of about
4.0M or greater. In some embodiments, the compound has a
solubility of about 5.0M or greater. In some embodiments,
the compound has a solubility in the non-aqueous liquid
electrolyte solution of about 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1,
1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5,
2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9,
4.0, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, or 5.0M. The
high solubility of the compounds disclosed herein in conjunction with the non-aqueous redox flow battery provides a
higher capacity battery that can be used in commercial
applications.
In some embodiments, the electro-active compound is
part of a polymer. In this regard, the relative concentration
of electro-active moiety can be described, rather than that of
the entire polymer chain. For example, if a repeat unit of
1,000 monomers was included, then the concentration of
monomer can be described, instead of the concentration the
polymer chain, because in that case, the concentration of
polymer would be about 1000x lower than the concentration
of electro-active moiety.
In some embodiments, the non-aqueous electrolyte solution comprises a metal halide salt. Non-limiting examples of
the metal halide salt include LiBF 4 , NaBF 4 , LiPF 6 , NaPF 6 ,
lithium bis(oxalato )borate, tetra-n-butylammonium hexafuorophosphate tetra-n-butylammonium bromide, tetra-nbutylammonium tetrafluoroborate. In some embodiments,
the electrolyte solution can include an ionic liquid dissolved
in an organic solvent. The ionic liquid dissolved in the
organic solvent can be, for example, an inorganic salt made
of the combination of cations including, but not limited
thereto, ammonium, immidazolium, piperidinium, pyrrolidinium, phophosium and sulfonium cations with anions

including, but not limited thereto, diethyl phosphate, bromide, iodide, chloride, methylsulfate, dodecylbenzenesulfonate,
trimethylpentyl)phosphinate,
dicyanamide,
decanoate, triflate, bis(trifluoromethylsulfonyl)imide, 1,1,2,
2-tetrafluoroethanesulfonate,
perfluorobutanesulfonate,
hexafluorophosphates,
tetrafluoroborates,
sulphate,
sulfonate, phosphate, thiocyanate, dicyanamide, acetate, trifluoroacetate, nitrate, tetrachloroferrate, tetrathiocyanocobaltate and methylcarbonate.
In some embodiments, the metal halide salt comprises a
cation such as, for example, Li+ and Na+. In some embodiments, the metal halide salt comprises anions such as, for
example, BF 4 -, PF 6 -, ClO4 -, AsF 6 -, CF 3 SO 3 -, N(SO 2
CF 3 ) 2 -, N(SO 2 CF 2 CF 3 ) 2 -, B(C 2 O4 ) 2 -, and B 12X 6 Hc 12
wherein X is a halogen.
The electrodes utilized according to the invention can
include metal, a carbon material, or a combination thereof.
Examples include platinum, copper, aluminum, nickel or
stainless steel, acetylene black, carbon black, activated carbon, amorphous carbon, graphite, graphene, or a nanostructured carbon material, or a combination thereof. The electrode can be porous, fluted, or smooth.
In some instances the redox flow battery includes the
redox flow battery shown in U.S. Patent Application Publication No. 2013/0224538 to Jansen et al., which is incorporated herein by this reference.
In some instances, the non-aqueous redox flow battery
provides stability over about 500 cycles, 600 cycles, 700
cycles, 800 cycles, 900 cycles or 1000 cycles or more.
While the terms used herein are believed to be well
understood by those of ordinary skill in the art, certain
definitions are set forth to facilitate explanation of the
presently-disclosed subject matter. Unless defined otherwise, all technical and scientific terms used herein have the
same meaning as is commonly understood by one of skill in
the art to which the invention(s) belong.
Where reference is made to a URL or other such identifier
or address, it understood that such identifiers can change and
particular information on the internet can come and go, but
equivalent information can be found by searching the internet. Reference thereto evidences the availability and public
dissemination of such information.
As used herein, the abbreviations for any protective
groups, amino acids and other compounds, are, unless
indicated otherwise, in accord with their common usage,
recognized abbreviations, or the IUPAC-IUB Commission
on Biochemical Nomenclature (see, Biochem. (1972) 11(9):
1726-1732).
Although any methods, devices, and materials similar or
equivalent to those described herein can be used in the
practice or testing of the presently-disclosed subject matter,
representative methods, devices, and materials are described
herein.
Following long-standing patent law convention, the terms
"a", "an", and "the" refer to "one or more" when used in this
application, including the claims.
Unless otherwise indicated, all numbers expressing quantities of ingredients, properties such as reaction conditions,
and so forth used in the specification and claims are to be
understood as being modified in all instances by the term
"about". Accordingly, unless indicated to the contrary, the
numerical parameters set forth in this specification and
claims are approximations that can vary depending upon the
desired properties sought to be obtained by the presentlydisclosed subject matter.
As used herein, the term "about," when referring to a
value or to an amount of mass, weight, time, volume,
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concentration or percentage is meant to encompass variations of in some embodiments ±20%, in some embodiments
±10%, in some embodiments ±5%, in some embodiments
±1%, in some embodiments ±0.5%, and in some embodiments ±0.1 % from the specified amount, as such variations
are appropriate to perform the disclosed method.
As used herein, ranges can be expressed as from "about"
one particular value, and/or to "about" another particular
value. It is also understood that there are a number of values
disclosed herein, and that each value is also herein disclosed
as "about" that particular value in addition to the value itself.
For example, if the value "10" is disclosed, then "about 10"
is also disclosed. It is also understood that each unit between
two particular units are also disclosed. For example, if 10
and 15 are disclosed, then 11, 12, 13, and 14 are also
disclosed.

equipped with a Pt honeycomb electrode card, used as the
working and the counter electrode and a freshly anodized
Ag/AgCl electrode, used as the reference electrode. UV-vis
spectra were obtained on an Agilent 8453 diode array
spectrometer and electrochemical analysis was performed
using a CH Instruments 650E potentiostat. First a UV-vis
spectrum and a cyclic voltammogram was recorded on the
sample. Bulk electrolysis (with coulometery) was then performed for 1 min at 0.1 V increments from 0 to 1.5 V and
then back to 0 V; followed by a UV-vis measurement at each
of those potentials. The chosen potential window was
obtained from cyclic voltammogram measurement.

EXAMPLES
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Example 1: Preparation of
3, 7 -dimethoxy-N-ethyl-phenothiazine
N-Ethy1-phenothiazine and 3, 7 -dibromo-N-ethy1-phenothiazine were prepared by previously reported procedures.
Odom, 2014 and Kaur, 2015.

Materials and Methods for Examples 1-3.
20
Hexanes, diethyl ether, and ethyl acetate were Macron
3, 7 -dimethoxy-N-ethyl-phenothiazine
brand purchased from VWR. Copper (I) iodide (98%) was
purchased from Acros Organics. Magnesium sulfate was
Sodium methoxide (-5M in methanol) solution was prepurchased from Fisher Scientific. Anhydrous methanol
pared by dissolving 0.25 g sodium (9.6 mmol) in 2.0 mL
(99.8%), anhydrous pyridine (99.8%), and sodium were 25 methanol in a round bottom flask at 0° C. under a N 2
purchased from Sigma-Aldrich. Silica gel (65x250 mesh)
atmosphere. To the resultant methoxide solution, Cul (763
was purchased from Sorbent Technologies. 1 H and 13 C
mg, 4.01 mmol), 3,7-dibromo-N-ethyl-phenothiazine (383
NMR spectra were obtained on Varian spectrometers in
g, 1.00 mmol), and pyridine (5 mL) were added. The
DMSO-d6 from Cambridge Isotope Laboratories. Propylene
reaction mixture was sparged with dry nitrogen for 15
carbonate and LiPF 6 were battery grade and purchased from 30 minutes. A reflux condenser was attached and the reaction
BASF Corporation (Florham Park, N.J.).
was heated at 120° C. for 12 hours. Upon completion of the
Dimethoxy-Substitutedphenothiazine Derivative Synthereaction, the reaction mixture was diluted with diethyl ether
sis:
and washed with brine. The organic extracts were dried over
Dimethoxy-substituted phenothiazine derivatives were
magnesium sulfate, filtered and concentrated under reduced
prepared in two steps from previously synthesized N-sub- 35 pressure. The organic residue was purified by silica gel
stituted phenothaizines (FIG. 2). In the first step, aromatic
chromatography using 0-10% ethyl acetate in hexane as
dibromination lead selectively to the 3,7-dibromophenothieluent to afford the product as a white crystalline solid (264
azine derivatives. Methoxylation of the dibromophemg) in 91 % yield. The product was further recrystallized
nothaizines was afforded by treatment with sodium methoxfrom aqueous methanol solution. 1 H NMR (DMSO-d6 , 400
ide and copper (I) iodide in refluxing pyridine. This reaction 40 MHz, ppm) Ii 6.88-6.90 (m, 2H), 6.75-6.77 (m, 4H), 3.79 (q,
afforded the desired products in 45-91 % yield. DMeOEPT
J=6.8 Hz, 2H), 3.33 (s, 6H), 1.24 (t, J=6.8 Hz, 3H), 13 C
(R=CH 2 CH 3 ) and DMeOMEPT (R=CH 2 CH 2 OCH 3 ) were
NMR (DMSO-d6 , 100 MHz, ppm) Ii 154.5, 138.4, 124.3,
isolated as white crystalline solids, while DMeOMEEPT
115.9, 112.9, 112.4, 55.4, 41.1, 12.8. GCMS: m/z 287
(R=(CH 2 CH 2 O) 2 CH 3 ) was isolated as a colorless oil. The
(41 %), 258 (100%), 215 (18%).Anal. calcd. forC 16H 17NOS
products were characterized by lH and 13C NMR, mass 45 C, 66.87; H, 5.96; N, 4.87. Found C, 66.70; H, 5.94; N, 4.95.
spectrometry, melting point (if crystalline), elemental analyMelting point: 115-116° C. (aq. MeOH).
sis and single crystal x-ray diffraction (if crystalline) to
confirm identity and purity.
Example 2: Preparation of
Electrochemical Analysis:
3, 7 -dimethoxy-N-methoxyethy1-phenothiazine
The cyclic voltammetry experiments illustrated in FIG. 3 50
3, 7-dibromo-N-methoxyethyl-phenothiazine
were performed with a CH Instruments 650E potentiostat
using a three-electrode system with glassy carbon as the
working electrode, Li metal as the reference electrode, and
N-methoxyethyl-phenothiazine (0.251 g, 0.973 mmol)
a Pt wire as a counter electrode. Each solution contained 10
was dissolved in DMF (3 mL). The reaction mixture was
mM analyte and 0.5M LiBF 4 in PC. Voltammograms were 55 cooled in an ice bath and N-bromosuccinimide (0.397 g,
recorded at a scan rate of 100 mV/s. Oxidation potentials are
2.23 mmol) was added portion-wise over 10 minutes. The
reported relative to Li+m_
reaction was allowed to warm to room temperature and
Spectroelectrochemistry:
stirred overnight. Upon completion of the reaction, the
The results of spectroelectrochemical measurements on
reaction mixture was diluted with ethyl acetate and washed
0.375 mM DMeOEPT in 0.lM LiTFSI in PC are illustrated 60 with water, sodium thiosulfate solution and brine. The
in FIG. 4. These data show that two distinct species are
organic extracts were dried over magnesium sulfate, filtered
formed at each oxidation event, further supporting the
and concentrated under reduced pressure. The organic resiformation of a radical cation, then a dication, in two separate
due was purified by silica gel chromatography using 0-10%
events, rather than one two-electron-transfer event. Spectroethyl acetate in hexane as eluent to afford the product as a
electrochemical measurements were performed using the 65 white crystalline solid (332 mg) in 82% yield. The product
spectroelectrochemical cell kit obtained from Pine research.
was further recrystallized from ethanol solution. 1 H NMR
1 mL of the sample solution was placed in the quartz cuvette
(DMSO-d 6 , 400 MHz, ppm) Ii 7.36 (m, 4H), 6.99 (m, 2H),
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4.01 (t, 1=5.6 Hz, 2H), 3.61 (t, 1=5.6 Hz, 2H), 3.24 (s, 3H).
13
C NMR (DMSO-d 6 , 100 MHz, ppm) Ii 143.6, 130.3,
129.0, 125.2, 117.5, 114.2, 68.6, 58.2, 47.0. GCMS: m/z
413/415/417 (61%), 368/370/372 (100%), 354/356/358
(22%), 336/338/340 (24%), 289/291 (42%), 196 (26%).
Anal. calcd. for C 15 H 13 NOSBr2 C, 43.40; H, 3.16; N, 3.37.
Found C, 43.45; H, 2.98; N, 3.25. Melting point: 88-89° C.
(EtOH).

methanol. To the methoxide solution, Cul (1.65 g, 8.68
mmol), DiBrMEEPT (1.00 g, 2.17 mmol) and pyridine (10.8
mL) were added. The reaction mixture was purged with
nitrogen for 15 minutes. A reflux condenser was attached
and the reaction was heated at 120° C. for 12 hours. Upon
completion of the reaction, the reaction mixture was diluted
with diethyl ether and washed with brine. The organic
extracts were dried over magnesium sulfate, filtered and
concentrated under reduced pressure. The organic residue
was purified by silica gel chromatography using 40% ethyl
acetate in hexane as eluent to afford the product as a
colorless syrup (350 mg) in 45% yield. 1 H NMR (DMSO-d 6 ,
400 MHz, ppm) Ii 6.93 (dt, 2H, 1=9.2, 1.4), 6.76 (m, 4H),
3.93 (t, 2H, 1=5.6), 3.69 (s, 6H), 3.68 (t, 2H, 1=5.6), 3.52 (m,
2H), 3.41 (m, 2H), 3.21 (s, 3H). 13 C NMR (DMSO-d6 , 100
MHz, ppm) ll 154.7, 138.5, 124.6, 116.1, 112.9, 112.4, 71.2,
69.6, 67.5, 58.0, 55.4, 47.3. GCMS: m/z 361 (77%), 272
(100%), 258 (78%), 240 (60%), 215 (26%), 172 (12%).
Anal. calcd. for C 19H 23 NO4 S C, 63.14; H, 6.41; N, 3.88.
Found C, 63.16; H, 6.55; N, 3.90.

3, 7-dimethoxy-N-methoxyethy1-phenothiazine
A concentrated sodium methoxide solution was prepared
by dissolving 0.13 g sodium (5.7 mmol) in 2 mL methanol.
To the methoxide solution, Cul (461 mg, 2.42 mmol),
3,7-dibromo-N-methoxyethyl-phenothiazine (0.249 g, 0.599
mmol) and pyridine (3 mL) were added. The reaction
mixture was sparged with nitrogen for 15 minutes. A reflux
condenser was attached and the reaction was heated at 120°
C. for 12 hours. Upon completion of the reaction, the
reaction mixture was diluted with diethyl ether and washed
with brine. The organic extracts were dried over magnesium
sulfate, filtered and concentrated under reduced pressure.
The organic residue was purified by silica gel chromatography using 0-10% ethy I acetate in hexane as eluent to afford
the product as a white crystalline solid (132 mg) in 69%
yield. The product was further recrystallized from ethanol
solution. 1 H NMR (DMSO-d 6 , 400 MHz, ppm) Ii 6.92 (m,
2H), 6.75 (m, 4H), 3.93 (t, 1=5.6 Hz, 2H), 3.69 (s, 6H), 3.59
(t, 1=5.6 Hz, 2H), 3.24 (s, 3H). 13 C NMR (DMSO-d 6 , 100
MHz, ppm) ll 154.7, 138.5, 124.6, 116.1, 112.9, 112.4, 69.0,
58.2, 55.4, 47.0. GCMS: m/z 317 (100%), 272 (100%), 258
(86%), 240 (73%), 215 (22%), 172 (13%). Anal. calcd. for
C 17H 19NO 3 S C, 64.33; H, 6.03; N, 4.41. Found C, 64.46; H,
6.01; N, 4.45. Melting point: 108-110° C. (EtOH).
Example 3: Preparation of 3,7-dimethoxy-N-((2methoxy )ethoxy )ethy1-phenothiazine
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25

Br

S

#

pyridine, 120° C.,
reflux 24 h
Br

(

35

40

45

50

55

60

3, 7-dimethoxy-N-((2-methoxy)ethoxy)ethyl-phenothiazine
65

Sodium methoxide (-3M in methanol) solution was prepared by dissolving 0.50 g sodium (22 mmol) in 7 mL

I~

30

3, 7-dibromo-N-( (2-methoxy )ethoxy )ethylphenothiazme
N-((2-methoxy)ethoxy)ethylphenothiazine (1.12 g, 3.73
mmol) was dissolved in anhydrous dichloromethane (DCM)
(11 mL) in a round-bottomed flask. The reaction mixture
was cooled in an ice bath and N-bromosuccinimide (2.0 g,
11.2 mmol) was added portion-wise over 10 minutes. The
reaction was allowed to stir at 0° C. for 30 min. Upon
completion of the reaction, the reaction mixture was
quenched with sodium thiosulfate, diluted with DCM, and
then the organic layer washed with water and brine. The
organic extracts were dried over magnesium sulfate, filtered
and concentrated under reduced pressure. The organic residue was purified by silica gel chromatography using 40%
ethyl acetate in hexane as eluent to afford the product as a
pale red syrup (1.03 g) in 60% yield. 1 H NMR (DMSO-d6 ,
400 MHz, ppm) Ii 7.35 (m, 4H), 7.00 (dd, 2H, 1=6.8, 2.8),
4.00 (t, 2H, 1=5.6), 3.69 (t, 2H, 1=5.6), 3.51 (m, 2H), 3.40
(m, 2H), 3.19 (s, 3H). 13 C NMR (DMSO-d 6 , 100 MHz,
ppm) ll 144.1, 130.8, 129.5, 125.7, 118.1, 114.6, 71.7, 70.1,
67.6, 58.5, 47.8. GCMS: m/z 457/459/461 (63%), 368/370/
372 (100%), 354/356/358 (25%), 336/338/340 (16%), 289/
291 (31%), 207 (18%), 196 (26%). Anal. calcd. for
C 17H 17NO 2 SBr2 C, 44.47; H, 3.73; N, 3.05. Found C, 44.61;
H, 3.74; N, 3.05.
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An oven-dried 1 L round-bottomed flask was transferred
to an argon filled glove box, then diethylene glycol monomethyl ether (390 mL, 3.41 mo!) was added into the roundbottomed flask and removed it from the glove box. Freshly
cut sodium metal (9.562 g, 415.5 mmol) was dissolved in
diethylene glycol monomethyl ether under nitrogen atmosphere. Then, copper (i) iodide (31.65 g, 168.2 mmol),
3,7-dibromo-N-ethylphenothiazine (16.00 g, 41.55 mmol)
and anhydrous pyridine (320 mL) were added to the resultant solution. After that reaction mixture was sparged with
nitrogen about 15 min while stirring. The round-bottomed
flask was immersed in an oil bath and heated to 120° C. for
overnight after connecting a reflux condenser. Upon completion of the reaction, reaction mixture was concentrated by
using rotovap. Then reaction mixture was diluted with ethyl
acetate and washed with IM aq. HCI, water and brine. The
combined organic extracts were dried over magnesium
sulphate and concentrated by using rotary evaporation.
Finally, organic residue was purified on a silica gel column
using 20-50% ethyl acetate in hexanes. The silica gel was
neutralized with trimethylamine (2-3 mL) during packing
the colunm. The product was yellow/light red viscous liquid
(14.8 g, 77%). A saturated solution of D(MEEO)EPT-BF 4
salt in DCM was prepared. A small volume was transferred
in a NMR tube and carefully layered it with toluene to form
two distinct layers. Finally, the NMR tube was capped and
placed in a freezer, and crystals formed at the interface of the
solvents. 1 H NMR (DMSO-d 6 , 400 MHz, ppm)) ll 6.90-6.85
(m, 2H), 6.79-6.75 (m, 4H), 4.05-3.98 (m, 4H), 3.79 (q,
1=6.9 Hz, 2H), 3.71-3.65 (m, 4H), 3.58-3.52 (m, 4H),
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3.47-3.41 (m, 4H), 3.23 (s, 6H), 1.23 (t, 1=6.9 Hz, 3H). 13 C
NMR ((DMSO-d6 , 100 MHz, ppm) Ii 153.91, 138.66,
124.47, 116.02, 113.79, 113.31, 71.47, 69.88, 69.14, 67.81,
58.26, 41.33, 12.93. GCMS: m/z 463 (100%), 434 (30%),
360 (11%), 230 (14%), 103(18%), 59(47%).Anal. calcd. for
C 24H 33 NO 6 S C, 62.18; H, 7.18; N, 3.02; 0, 20.71; S, 6.92.
Found C, 62.40; H, 7.22; N, 3.03.
Discussion of Examples:
Preliminary experiments to determine the stability of
dialkoxyphenothiazines on longer timescales were accomplished by half-cell cycling experiments versus lithium
metal. Active material was dissolved at 0.01M in 0.5M
LiBF 4 /PC and soaked into a graphite felt electrode. A 2032
coin cell was assembled with the graphite felt, a lithiated
Nafion membrane and lithium metal. For one-electron transfer reactions, the coin cell was cycled between 3.1 and 3.6
V. All three dialkyoxybenzene shows high stability in oneelectron cycling with high coulombic efficiency (>95% over
100 cycles) and little loss of active material over 100 cycles
(FIGS. 5-7). Such performance suggests that the first oxidation state of these compounds is highly stable and does not
react or decompose leading to decreased capacities. Crossover and premature reaction of the oxidized species at the
lithium anode may account for the small loss in coloumbic
efficiency.
For two-electron transfer reactions, the coin cell was
cycled between 3.1 and 4.2 Vin order to access the second
oxidation state of the dialkoxyphenothiazines. Roughly
twice the capacity of the one-electron experiment is
observed but with reduced coulombic efficiency (about
80-90% ). The reduced coulombic efficiency is likely due to
extended charging times leading to increased membrane
crossover and premature reduction of the active material.
Little loss of active material is observed which is promising
as it again suggests that the material is stable in its second
oxidation state form. Additionally, as shown by the cyclic
voltammetry experiments discussed above (FIG. 3), both
first and second oxidation events were reversible and were
observed at about 3.4 V and 4.0 V for all three compounds.
All patents, patent applications, publications, and other
published materials mentioned in this specification, unless
noted otherwise, are herein incorporated by reference to the
same extent as if each individual publication, patent, or
patent application was specifically and individually indicated to be incorporated by reference, including the references set forth in the following list:

5. Wei, X.; Cosimbescu, L.; Xu, W.; Hu, J. Z.; Vijayakumar,
M.; Feng, J.; Hu, M. Y.; Deng, X.; Xiao, J.; Liu, J.;
Sprenkle, V.; Wang, W. Adv. Energy Mater. 2015, 5,
1400678.
6. Huang, J.; Cheng, L.; Assary, R. S.; Wang, P.; Xue, Z.;
Burrell, A. K.; Curtiss, L. A.; Zhang, L. Adv. Energy
Mater. 2015, 5, n/a-n/a.
7. Wei, X.; Xu, W.; Vijayakumar, M.; Cosimbescu, L.; Liu,
T.; Sprenkle, V.; Wang, W. Adv. Mater. 2014, 26, 76497653.
8. Casselman, M. D.; Kaur, A. P.; Narayana, K. A.; Elliott,
C. F.; Risko, C.; Odom, S. A. Phys. Chem. Chem. Phys.
2015, 17, 6905-6912.
9. Kaur, A. P.; Holubowitch, N. E.; Ergun, S.; Elliott, C. F.;
Odom, S. A. Energy Technol. 2015, 3, 476-480.
10. Odom, S. A.;* Ergun, S.; Poudel, P. P.; Parkin, S. R.
Energy and Environmental Sciences, 2014, 7, 760-767.
DOI: 10.1039/C3EE42305K.
11. Kaur, A. P.; C. F.; Ergun, S.; Odom, S. A.,* Journal of
the Electrochemical Society, 2016, 163, Al-A7. DOI:
10.1149/2.0951514jes
It will be understood that various details of the presently
disclosed subject matter can be changed without departing
from the scope of the subject matter disclosed herein.
Furthermore, the foregoing description is for the purpose of
illustration only, and not for the purpose of limitation.
We claim:
1. A compound selected from the group consisting of:
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2. The non-aqueous flow-battery, comprising:
a negative electrode immersed in a first non-aqueous
liquid electrolyte solution;
a positive electrode immersed in a second non-aqueous
liquid electrolyte solution, the second non-aqueous
liquid electrolyte solution including at least one compound according to claim 1; and
a semi-permeable separator interposed between the negative and positive electrodes.
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